|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Pathologist variation in reporting cervical borderline epithelial abnormalities and cervical intraepithelial neoplasia显示文摘 | Creagh T Bridger JE Kupek E Fish DE Martin-Bates E Wilkins MJ | 1995 | J Clin Pathol1995，48，1： | 1 |
| 2 | Double-free, flow-through flap reconstruction for complex scalp defects: case report 显示文摘 | Haddock MC Creagh T Sivarajanlp V | 2011 | Micro- surgery2011，31，4： | 1 |
| 3 | Zidovudine Epidemiology Study Group Incidence and natural history of Mycobacterium avium complex infections in patients with advanced human immunodeficiency virus disease treated with zidovudine显示文摘 | Chaisson RE Moore RD Richman DD Keruly J Creagh T | 1992 | Am Rev Respir Dis1992，146，： | 1 |
| 4 | Safety and pharmacokinetics of single doses of ( + )-calanolide A, a novel, naturally occurring nonnucleoside reverse transcriptase inhibitor, in healthy, human immunode- ficiency virus-negative human subjects 显示文摘 | Creagh T Ruckle JL Tolbert DT | 2001 | Antimicrob Agents Chemother2001，45，： | 1 |
| 5 | Safety and pharmacokinetic profile of multiple escalating doses of ( + )-calanolide A, a naturally occurring nonnucleoside reverse transcriptase inhibitor, in healthy HIV-negative volunteers 显示文摘 | Eiznhamer DA Creagh T Ruckle JL | 2002 | HIV Clin Trials2002，3，： | 1 |
| 6 | Training and injuries amongst elite female orienteers显示文摘 | Creagh U Reilly T | 1998 | J Sports Med Phys Fitness 38:75 - 791998，，： | 1 |
| 7 | Safety and pharmacokinetics of single doses of ( + )-calanolide A, a novel, naturally occurring nonnucleoside reverse transcriptase inhibitor, in healthy, human immunodeficiency virus-negative human subjects 显示文摘 | Creagh T Ruckle JL Tolbert DT | | A0，，： | 1 |
| 8 | Interstitial cystitis/painful bladder syndrome: epidemiology, pathophysiol- ogy and evidence- based treatment options显示文摘 | Davis N F Brady C M Creagh T | 2014 | Eur J Obstet Gynecol Reprod Biol2014，175，： | 1 |
| 9 | Physiological and Biomechanical Aspects of Orienteering显示文摘 | Creagh U Reilly T | 1997 | Sports med1997，，6： | 1 |
| 10 | Heart rate response to“offroad”running events in female athletes显示文摘 | Creagh U Reilly T Nevill AM | 1998 | Br J Sports Med1998，，1： | 1 |
| 11 | Do not treat staghorn calculi by extracorporea shock wave lith otripsy alone显示文摘 | Delaney C P Creagh T A Smith J M | 1993 | Eur Urol1993，24，： | 1 |
| 12 | Double-free,flow-through flap reconstruction for complex scalp defects:a case report显示文摘 | Haddock M C Creagh T Sivarajan V | 2011 | Microsurgery2011，31，4： | 1 |
| 13 | Safety and pharmacokinetics of single doses of (+)-calanolide A, a novel, naturally occurring nonnucleoside reverse transcriptase inhibitor, in healthy, human immunodeficiency virus-negative human subjects 显示文摘 | Creagh T Ruckle JL Tolbert DT | 2001 | Antimicrob Agents Chemother2001，45，： | 1 |
| 14 | Heat shockprotein 70inhibits caspase-dependent and-independent apopto-sis in Jurkat T cells显示文摘 | CREAGH E M CARMODY R J COTTER T G | 2000 | Exp Cell Res2000，257，1： | 1 |
| 15 | Interstitial cystitis/painful bladder syndrome:epidemiology,pathophysiology and evidence-based treatment options显示文摘 | Davis N F Brady C M Creagh T | 2014 | Eur J Obstet Gynecol Reprod Biol2014，175，1： | 1 |
| 16 | Pharmacological ma- nipulation of acute cyclosporin ischemic renal injury with trimetazidine显示文摘 | T Creagh D Lanigan J Dolan | 1993 | The Journal of Urology1993，149，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员